tradingkey.logo
tradingkey.logo
Search

Edap Tms SA

EDAP
Add to Watchlist
4.320USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
194.17MMarket Cap
LossP/E TTM

More Details of Edap Tms SA Company

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

Edap Tms SA Info

Ticker SymbolEDAP
Company nameEdap Tms SA
IPO dateAug 01, 1997
CEORhodes (Ryan)
Number of employees310
Security typeDepository Receipt
Fiscal year-endAug 01
Address4, rue du Dauphine
CityVAULX-EN-VELIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryFrance
Postal code69120
Phone33472153150
Websitehttps://focalone.com/fr/accueil/
Ticker SymbolEDAP
IPO dateAug 01, 1997
CEORhodes (Ryan)

Company Executives of Edap Tms SA

Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
-7.52%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
637.83K
+47.74%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
-7.52%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
637.83K
+47.74%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--

FAQs

Who are the top five shareholders of Edap Tms SA?

The top five shareholders of Edap Tms SA are: Dr. Lance Willsey

How many institutions hold shares of Edap Tms SA (EDAP)?

As of 2026Q1, 70 institutions hold shares of Edap Tms SA, with a combined market value of approximately 14.62M, accounting for 39.01% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -711403.00.